Latest Form 4 insider transactions

Doug Black, CEO and a Director of SiteOne Landscape Supply, Inc., purchased 8,000 shares of common stock on August 4, 2026.

Rita J. Heise, a Director of Fastenal Co, sold 34,964 shares of common stock on August 5, 2026 for $50.05 per share.

David E Rainbolt, a Director and 10% owner of Bancfirst Corp /Ok/, sold 3,000 shares of common stock on August 6, 2026 for $115.00 per share.

Paulson & Co. Inc. reported changes in beneficial ownership of Thryv Holdings, Inc. common stock on August 4, 2026.

Charles G.T. Stonehill, a Director of Alliancebernstein Holding L.P., sold 5,000 shares of common stock on August 4, 2026 for $37.17 per share.

Andy Heyward, CEO and Chairman and a Director of Kartoon Studios, Inc., reported a transaction in 20,903 shares of common stock on August 5, 2026.

Craig A Lampo, EVP& CFO of Amphenol Corp /De/, reported a transaction in 54,547 shares of common stock on August 6, 2026.

Chen Lok Ng, Chief Executive Officer, a Director and 10% owner of SAGTEC GLOBAL Ltd, purchased 300,000 shares of common stock on July 31, 2026 for $0.77 per share.

Xin Yee Loong, Chief Operating Officer of SAGTEC GLOBAL Ltd, purchased 62,500 shares of common stock on July 31, 2026 for $0.77 per share.

Craig Ridenhour, President and a Director of AtlasClear Holdings, Inc., reported multiple transactions in common stock on July 14, 2026.

Columbus Acquisition Corp. has amended its business combination agreement, extending the outside date to October 31, 2026, and detailing a $10 million PIPE investment.

Ryan Nicholson, VP, CAO and Corp. Controller of Dolby Laboratories, Inc., sold 357 shares of common stock on August 4, 2026 for $60.63 per share.

Raymond F O'Conor, a Director of Arrow Financial Corp, reported multiple transactions in common stock on August 4, 2026.

Cas Katherine Dei, President, Semiconductor of Qnity Electronics, Inc., received 2,937 shares of common stock on August 5, 2026.

Mark Behan, a Director of Arrow Financial Corp, reported multiple transactions in common stock on August 4, 2026.

Dana Incorporated announced robust second quarter 2026 financial results, highlighted by increased sales and adjusted EBITDA, alongside significant updates to its proposed business combination with Eaton's Mobility business.

Kristopher J Matula, a Director of BOISE CASCADE Co, sold 1,930 shares of common stock on August 5, 2026 for $84.58 per share.

Gerald Dischler, a Director of Hubspot Inc, received 1,015 shares of common stock on August 5, 2026.

Carl Ledbetter, a Director of Cloudflare, Inc., sold 5,000 shares of common stock on August 6, 2026.

Cyclerion Therapeutics and Korsana Biosciences have entered into a merger agreement, aiming to combine their operations and advance drug development pipelines.

Matthew B. Klein, CHIEF EXECUTIVE OFFICER and a Director of Ptc Therapeutics, Inc., sold 10,292 shares of common stock on August 4, 2026 for $68.57 per share.

Rezolve Ai criticizes Commerce.com's Q2 results, citing flat revenue, declining subscriptions, and reduced guidance, contrasting sharply with Rezolve Ai's substantial growth.

Rezolve Ai criticizes Commerce.com's Q2 results, citing flat revenue, declining subscriptions, and reduced guidance, contrasting sharply with Rezolve Ai's substantial growth.

Kirsten M Volpi, a Director of Tetra Tech Inc, reported multiple transactions in common stock on August 4, 2026.

Larry Peiros, a Director of Once Upon a Farm, PBC, reported multiple transactions in common stock on August 5, 2026.

Cerberus GP Manager LLC and 3 others reported changes in beneficial ownership of Eos Energy Enterprises, Inc. common stock on August 4, 2026.

Todd A. Everett, EVP and President of SendTech of Pitney Bowes Inc /De/, sold 25,000 shares of common stock on August 5, 2026 for $18.07 per share.

Robert M Cortopassi, President and COO of Global Payments Inc, reported a transaction in 2,955 shares of common stock on August 4, 2026.

Brian L Roberts, Chairman of Board & Co-CEO and a Director of Comcast Corp, reported a transaction in 204,100 shares of common stock on August 5, 2026.

Phillip Frost, a Director and 10% owner of Cocrystal Pharma, Inc., purchased 10,000 shares of common stock on August 5, 2026 for $0.98 per share.